Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microbial Bioremediation of Pesticides01:28

Microbial Bioremediation of Pesticides

Pesticides often feature structurally complex chemical architectures, incorporating halogen groups and multiple aromatic rings. These characteristics confer high chemical stability, rendering many pesticides resistant to natural degradation processes. This resistance poses significant environmental concerns, as persistent pesticide residues can accumulate in ecosystems and affect non-target organisms.Despite the inherent stability of many pesticides, certain microorganisms possess the metabolic...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Drug Metabolism: Phase I Reactions01:17

Drug Metabolism: Phase I Reactions

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peptide crosslinking by cytochrome P450 enzymes: Diversity, discovery and developments.

Current opinion in chemical biology·2026
Same author

Investigating the P450-Mediated Cross-Linking of the Atypical GPA Complestatin Using Alternate Peptide Probes.

The Journal of organic chemistry·2026
Same author

P450 Cyptide Synthase AscB Catalyzes Fused Cyclophane at the YxWxH Motif on the Precursor Peptides.

Organic letters·2026
Same author

Methylene Peptide Backbone Substitution Significantly Affects the Glycopeptide Antibiotic Cross-Linking Cascade.

ACS chemical biology·2026
Same author

An integrated multi-omic approach for discovery and dereplication of bioactive microbial natural products.

Microbial genomics·2025
Same author

Biosynthesis of Biphenomycin-like Macrocyclic Peptides by Formation and Cross-Linking of <i>Ortho</i>-Tyrosines.

Journal of the American Chemical Society·2025

Related Experiment Video

Updated: Jun 10, 2026

2 in 1: One-step Affinity Purification for the Parallel Analysis of Protein-Protein and Protein-Metabolite Complexes
08:23

2 in 1: One-step Affinity Purification for the Parallel Analysis of Protein-Protein and Protein-Metabolite Complexes

Published on: August 6, 2018

Selectivity in a barren landscape: the P450(BioI)-ACP complex.

Max J Cryle1

  • 1Department of Biomolecular Mechanisms, Max-Planck Institute for Medical Research, Jahnstrasse 29, 69120 Heidelberg, Germany. Max.Cryle@mpimf-heidelberg.mpg.de

Biochemical Society Transactions
|July 28, 2010
PubMed
Summary

Cytochromes P450 (P450s) are versatile enzymes. This study details P450(BioI), which uses a carrier protein to hydroxylate fatty acids, forming a biotin precursor.

More Related Videos

High-throughput Siderophore Screening from Environmental Samples: Plant Tissues, Bulk Soils, and Rhizosphere Soils
12:36

High-throughput Siderophore Screening from Environmental Samples: Plant Tissues, Bulk Soils, and Rhizosphere Soils

Published on: February 9, 2019

Bacterial Peptide Display for the Selection of Novel Biotinylating Enzymes
10:43

Bacterial Peptide Display for the Selection of Novel Biotinylating Enzymes

Published on: October 3, 2019

Related Experiment Videos

Last Updated: Jun 10, 2026

2 in 1: One-step Affinity Purification for the Parallel Analysis of Protein-Protein and Protein-Metabolite Complexes
08:23

2 in 1: One-step Affinity Purification for the Parallel Analysis of Protein-Protein and Protein-Metabolite Complexes

Published on: August 6, 2018

High-throughput Siderophore Screening from Environmental Samples: Plant Tissues, Bulk Soils, and Rhizosphere Soils
12:36

High-throughput Siderophore Screening from Environmental Samples: Plant Tissues, Bulk Soils, and Rhizosphere Soils

Published on: February 9, 2019

Bacterial Peptide Display for the Selection of Novel Biotinylating Enzymes
10:43

Bacterial Peptide Display for the Selection of Novel Biotinylating Enzymes

Published on: October 3, 2019

Area of Science:

  • Biochemistry
  • Enzymology
  • Molecular Biology

Background:

  • Cytochromes P450 (P450s) are crucial oxidative enzymes involved in diverse metabolic processes.
  • Fatty acid hydroxylation by P450s is essential in various biological systems, with varying substrate specificity.
  • P450(BioI) (CYP107H1) from Bacillus subtilis is a P450 enzyme involved in biotin biosynthesis.

Purpose of the Study:

  • To investigate the structure and function of P450(BioI) in the context of fatty acid metabolism.
  • To elucidate the mechanism by which P450(BioI) interacts with its carrier protein and substrates.
  • To provide structural insights into a unique class of P450 enzymes that utilize carrier proteins.

Main Methods:

  • Structural characterization of the P450(BioI)-acyl-carrier protein (ACP) complex.
  • Biochemical assays to study the enzymatic activity of P450(BioI).
  • Analysis of the P450(BioI)-ACP complex structure to understand substrate presentation and oxidation mechanisms.

Main Results:

  • The study determined the first crystal structure of a P450-carrier protein complex, specifically P450(BioI)-ACP.
  • The structure reveals how the acyl-carrier protein presents long-chain fatty acids to P450(BioI) for oxidative cleavage.
  • P450(BioI) catalyzes the formation of pimelic acid, a key intermediate in biotin biosynthesis, through hydroxylation of fatty acids.

Conclusions:

  • The P450(BioI)-ACP structure provides critical insights into the mechanism of fatty acid oxidation by P450 enzymes that interact with carrier proteins.
  • This work illuminates a novel mechanism for substrate delivery and activation in P450-mediated biosynthesis.
  • The findings have implications for understanding and engineering other P450-carrier protein systems in various biological pathways.